Widening the use of deep brain stimulation: Ethical considerations in research on DBS to treat Anorexia Nervosa

Quick Read

Adina Roskies: As treatments advance, interventions into brain function will dramatically illustrate the dependence of who we are on our brains – and they may put pressure on some basic beliefs and concepts that have been fundamental to how we view the world

Quick Read

Long-awaited regulations may curb rogue clinics offering unproven treatments

Quick Read

Myanmar’s healthcare crisis: As Myanmar prepares for a historic election on 8 November 2015, its leadership is rolling out plans for dramatic health sector reforms. But there are enormous obstacles, including the legacy of war and a rising threat of drug-resistant infectious diseases in restive border areas. Mike Ives reports

Quick Read

New antibody drugs show promise in slowing the advance of Alzheimer’s disease (Image: Dwayne Reed at en.wikipedia)

Quick Read

Chemotherapy has saved countless lives and is a mainstay of cancer care. But the latest data suggests that it can also do more harm than good for some patients

Quick Read

Q & A with Johns Hopkins Catalyst Award Winner Carlton Haywood Jr about his intervention designed to improve healthcare provider attitudes and beliefs about patients with sickle cell disease

Read More

Johnson & Johnson has appointed Arthur Caplan, a nationally known bioethicist, to create a panel that will make decisions about patients’ requests for potentially lifesaving medicine, responding to an emotional debate over whether companies should allow desperately ill people to have access to the drugs before they are approved

Quick Read